The University of Arizona

Study of Lebrikizumab

Summary: 

A study of the effectiveness and safety of Lebrikizumab in treating patients with Idiopathic Pulmonary Fibrosis.

Sponsor: 
Hoffmann-La Roche

Researchers: 

Research Specialties: 
Pulmonary


Fatal error: Class 'FeedsHTTPCache' not found in /home/arcadmin/public_html/sites/all/modules/feeds/feeds.module on line 82